Challenges in the optimisation of post-operative pain management with opioids in obese patients: A literature review

Obesity Surgery

Volumn 23, Issue 9, 2013, Pages 1458-1475

  Lloret Linares, C ^a,b   Lopes, A ^a   Decleves X ^b   Serrie, A ^b   Mouly, S ^a,b   Bergmann, J F ^a,b   Perrot, S ^c,d  

^a INSERM   (France)

^b HÔPITAL LARIBOISIÈRE   (France)

^c HÔTEL DIEU   (France)

^d HÔPITAL AMBROISE PARÉ   (France)

Author keywords

Analgesia; Morphine; Obesity; Post operative pain; Surgery

Indexed keywords

BUPIVACAINE; DEXMEDETOMIDINE; FENTANYL; KETOBEMIDONE; KETOROLAC; MORPHINE; OPIATE; PETHIDINE; PIRITRAMIDE; PREGABALIN; REMIFENTANIL; SUFENTANIL; TRAMADOL;

ANALGESIC ACTIVITY; DISEASE ASSOCIATION; DRUG CLEARANCE; DRUG DISTRIBUTION; DRUG EFFICACY; DRUG HALF LIFE; DRUG METABOLISM; DRUG SAFETY; GASTROPLASTY; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; HOSPITALIZATION; HUMAN; LAPAROSCOPIC VERTICAL BANDING GASTROPLASTY; LAPAROTOMY; LENGTH OF STAY; LIPOPHILICITY; LUNG ALVEOLUS HYPOVENTILATION; MOBILIZATION; MORBID OBESITY; NAUSEA; NAUSEA AND VOMITING; NEUROPATHIC PAIN; NOCICEPTION; PAIN ASSESSMENT; PATIENT SATISFACTION; POSTOPERATIVE PAIN; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PRURITUS; REHABILITATION; REVIEW; SINGLE DRUG DOSE; SLEEP DISORDERED BREATHING; SLEEVE GASTRECTOMY; STOMACH BYPASS; SURGICAL TECHNIQUE; VISUAL ANALOG SCALE;

ANALGESICS, OPIOID; BARIATRIC SURGERY; BODY MASS INDEX; DRUG ADMINISTRATION SCHEDULE; FEMALE; FRANCE; HUMANS; MALE; OBESITY, MORBID; PAIN MEASUREMENT; PAIN, POSTOPERATIVE; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, OPIOID, MU;

EID: 84881181373     PISSN: 09608923     EISSN: 17080428     Source Type: Journal    
DOI: 10.1007/s11695-013-0998-8     Document Type: Review

References (83)

1. Franklin J, Ingvarsson T, Englund M, et al. Sex differences in the association between body mass index and total hip or knee joint replacement resulting from osteoarthritis. Ann Rheum Dis. 2009;68:536-40.
2. Cremieux PY, Buchwald H, Shikora SA, et al. A study on the economic impact of bariatric surgery. Am J Manag Care. 2008;14:589-96.
3. Schug SA, Raymann A. Postoperative pain management of the obese patient. Best Pract Res Clin Anaesthesiol. 2011;25:73-81.
4. Carlsson LM, Peltonen M, Ahlin S, et al. Bariatric surgery and prevention of type 2 diabetes in Swedish obese subjects. N Engl J Med. 2012;367:695-704.
5. Sjostrom L, Narbro K, Sjostrom CD, et al. Effects of bariatric surgery on mortality in Swedish obese subjects. N Engl J Med. 2007;357:741-52. (Pubitemid 47295641)
6. Nguyen NT, Root J, Zainabadi K, et al. Accelerated growth of bariatric surgery with the introduction of minimally invasive surgery. Arch Surg. 2005;140:1198-202. discussion 1203. (Pubitemid 41815903)
7. Samson AJ, Mercer GE, Campbell DG. Total knee replacement in the morbidly obese: a literature review. ANZ J Surg. 2010;80:595-9.
8. Schouten JS, van den Ouweland FA, Valkenburg HA. A 12 year follow up study in the general population on prognostic factors of cartilage loss in osteoarthritis of the knee. Ann Rheum Dis. 1992;51:932-7.
9. Felson DT, Zhang Y, Hannan MT, et al. Risk factors for incident radiographic knee osteoarthritis in the elderly: the Framingham Study. Arthritis Rheum. 1997;40:728-33. (Pubitemid 27157580)
10. Dougados M, Gueguen A, Nguyen M, et al. Longitudinal radiologic evaluation of osteoarthritis of the knee. J Rheumatol. 1992;19:378-84.
11. Rajgopal V, Bourne RB, Chesworth BM, et al. The impact of morbid obesity on patient outcomes after total knee arthroplasty. J Arthroplasty. 2008;23:795-800.
12. Ingrande J, Lemmens HJ. Dose adjustment of anaesthetics in the morbidly obese. Br J Anaesth. 2010;105 Suppl 1:i16-23.
13. Ronellenfitsch U, Schwarzbach M, Kring A, et al. The effect of clinical pathways for bariatric surgery on perioperative quality of care. Obes Surg. 2012;22:732-9.
14. Priano L, Miscio G, Grugni G, et al. On the origin of sensory impairment and altered pain perception in Prader-Willi syndrome: a neurophysiological study. Eur J Pain. 2009;13:829-35.
15. Farooqi S, O'Rahilly S. Genetics of obesity in humans. Endocr Rev. 2006;27:710-8. (Pubitemid 44936054)
16. Beckers S, Peeters A, Zegers D, et al. Association of the BDNF Val66Met variation with obesity in women. Mol Genet Metab. 2008;95:110-2.
17. Wu L, Xi B, Zhang M, et al. Associations of six single nucleotide polymorphisms in obesity-related genes with BMI and risk of obesity in Chinese children. Diabetes. 2010;59:3085-9.
18. Vossen H, Kenis G, Rutten B, et al. The genetic influence on the cortical processing of experimental pain and the moderating effect of pain status. PLoS One. 2010;5:e13641.
19. Lloret Linares C, Hajj A, Poitou C, et al. Pilot study examining the frequency of several gene polymorphisms involved in morphine pharmacodynamics and pharmacokinetics in a morbidly obese population. Obes Surg. 2011;21:1257-64.
20. Miscio G, Guastamacchia G, Brunani A, et al. Obesity and peripheral neuropathy risk: a dangerous liaison. J Peripher Nerv Syst. 2005;10:354-8.
21. Dodet P, Perrot S, Auvergne L, et al. Sensory impairment in obese patients? Sensitivity and pain detection thresholds for electrical stimulation after surgery-induced weight loss, and comparison with a nonobese population. Clin J Pain. 2013;29:43-9.
22. Stener-Victorin E, Kowalski J, Lundeberg T. A new highly reliable instrument for the assessment of pre- and postoperative gynecological pain. Anesth Analg. 2002;95:151-7. table of contents. (Pubitemid 34705570)
23. Lundblad H, Kreicbergs A, Jansson KA. Prediction of persistent pain after total knee replacement for osteoarthritis. J Bone Joint Surg Br. 2008;90:166-71. (Pubitemid 351303341)
24. Nielsen PR, Norgaard L, Rasmussen LS, et al. Prediction of post-operative pain by an electrical pain stimulus. Acta Anaesthesiol Scand. 2007;51:582-6. (Pubitemid 46570035)
25. Khan F, Ng L, Gonzalez S, Hale T et al. Multidisciplinary rehabilitation programmes following joint replacement at the hip and knee in chronic arthropathy. Cochrane Database Syst Rev 2008:CD004957.
26. Cheville A, Chen A, Oster G, et al. A randomized trial of controlled-release oxycodone during inpatient rehabilitation following unilateral total knee arthroplasty. J Bone Joint Surg Am. 2001;83-A:572-6. (Pubitemid 32294939)
27. Nunez M, Lozano L, Nunez E, et al. Total knee replacement and health-related quality of life: factors influencing long-term outcomes. Arthritis Rheum. 2009;61:1062-9.
28. Vincent HK, Vincent KR, Lee LW, et al. Effect of obesity on inpatient rehabilitation outcomes following total knee arthroplasty. Clin Rehabil. 2007;21:182-90. (Pubitemid 46323070)
29. Livhits M, Mercado C, Yermilov I, et al. Behavioral factors associated with successful weight loss after gastric bypass. Am Surg. 2010;76:1139-42.
30. Chumlea WC, Guo SS, Zeller CM, et al. Total body water reference values and prediction equations for adults. Kidney Int. 2001;59:2250-8. (Pubitemid 32467618)
31. Ciangura C, Bouillot JL, Lloret-Linares C, et al. Dynamics of change in total and regional body composition after gastric bypass in obese patients. Obesity (Silver Spring). 2010;18:760-5.
32. Young JF, Luecke RH, Pearce BA, et al. Human organ/tissue growth algorithms that include obese individuals and black/white population organ weight similarities from autopsy data. J Toxicol Environ Health A. 2009;72:527-40.
33. Poirier P, Giles TD, Bray GA, et al. Obesity and cardiovascular disease: pathophysiology, evaluation, and effect of weight loss: an update of the 1997 American Heart Association Scientific Statement on Obesity and Heart Disease from the Obesity Committee of the Council on Nutrition, Physical Activity, and Metabolism. Circulation. 2006;113:898-918.
34. Edholm D, Kullberg J, Haenni A, et al. Preoperative 4-week low-calorie diet reduces liver volume and intrahepatic fat, and facilitates laparoscopic gastric bypass in morbidly obese. Obes Surg. 2011;21:345-50.
35. Valensi P, Assayag M, Busby M, et al. Microalbuminuria in obese patients with or without hypertension. Int J Obes Relat Metab Disord. 1996;20:574-9. (Pubitemid 26174344)
36. Ribstein J, du Cailar G, Mimran A. Combined renal effects of overweight and hypertension. Hypertension. 1995;26:610-5.
37. Chagnac A, Weinstein T, Korzets A, et al. Glomerular hemodynamics in severe obesity. Am J Physiol Renal Physiol. 2000;278:F817-822.
38. Fabbrini E, Sullivan S, Klein S. Obesity and nonalcoholic fatty liver disease: biochemical, metabolic, and clinical implications. Hepatology. 2010;51:679-89.
39. Tilg H, Kaser A. Gut microbiome, obesity, and metabolic dysfunction. J Clin Invest. 2011;121:2126-32.
40. Lumeng CN, Saltiel AR. Inflammatory links between obesity and metabolic disease. J Clin Invest. 2011;121:2111-7.
41. Lickteig AJ, Slitt AL, Arkan MC, et al. Differential regulation of hepatic transporters in the absence of tumor necrosis factor-alpha, interleukin-1beta, interleukin-6, and nuclear factor-kappaB in two models of cholestasis. Drug Metab Dispos. 2007;35:402-9. (Pubitemid 46333903)
42. Vee ML, Lecureur V, Stieger B, et al. Regulation of drug transporter expression in human hepatocytes exposed to the proinflammatory cytokines tumor necrosis factor-alpha or interleukin-6. Drug Metab Dispos. 2009;37:685-93.
43. More VR, Slitt AL. Alteration of hepatic but not renal transporter expression in diet-induced obese mice. Drug Metab Dispos. 2011;39:992-9.
44. Buechler C, Weiss TS. Does hepatic steatosis affect drug metabolizing enzymes in the liver? Curr Drug Metab. 2011;12:24-34.
45. Sugioka N, Haraya K, Fukushima K, et al. Effects of obesity induced by high-fat diet on the pharmacokinetics of nelfinavir, a HIV protease inhibitor, in laboratory rats. Biopharm Drug Dispos. 2009;30:532-41.
46. Nawa A, Fujita-Hamabe W, Tokuyama S. Altered intestinal P-glycoprotein expression levels in a monosodium glutamate-induced obese mouse model. Life Sci. 2011;89:834-8.
47. Cheng Q, Aleksunes LM, Manautou JE, et al. Drug-metabolizing enzyme and transporter expression in a mouse model of diabetes and obesity. Mol Pharm. 2008;5:77-91. (Pubitemid 351300037)
48. Brill MJ, Diepstraten J, van Rongen A, et al. Impact of obesity on drug metabolism and elimination in adults and children. Clin Pharmacokinet. 2012;51:277-304.
49. Hanley MJ, Abernethy DR, Greenblatt DJ. Effect of obesity on the pharmacokinetics of drugs in humans. Clin Pharmacokinet. 2010;49:71-87.
50. Lloret Linares C, Decleves X, Oppert JM, et al. Pharmacology of morphine in obese patients: clinical implications. Clin Pharmacokinet. 2009;48:635-51.
51. Graves DA, Batenhorst RL, Bennett RL, et al. Morphine requirements using patient-controlled analgesia: influence of diurnal variation and morbid obesity. Clin Pharm. 1983;2:49-53. (Pubitemid 13181545)
52. Tateishi T, Krivoruk Y, Ueng YF, et al. Identification of human liver cytochrome P-450 3A4 as the enzyme responsible for fentanyl and sufentanil N-dealkylation. Anesth Analg. 1996;82:167-72. (Pubitemid 26017401)
53. Schwartz AE, Matteo RS, Ornstein E, et al. Pharmacokinetics of sufentanil in obese patients. Anesth Analg. 1991;73:790-3.
54. Slepchenko G, Simon N, Goubaux B, et al. Performance of target-controlled sufentanil infusion in obese patients. Anesthesiology. 2003;98:65-73. (Pubitemid 36043411)
55. Shibutani K, Inchiosa Jr MA, Sawada K, et al. Pharmacokinetic mass of fentanyl for postoperative analgesia in lean and obese patients. Br J Anaesth. 2005;95:377-83. (Pubitemid 41487352)
56. Murugan AT, Sharma G. Obesity and respiratory diseases. Chron Respir Dis. 2008;5:233-42.
57. Juvin P, Lavaut E, Dupont H, et al. Difficult tracheal intubation is more common in obese than in lean patients. Anesth Analg. 2003;97:595-600. table of contents. (Pubitemid 36899772)
58. Ahmad S, Nagle A, McCarthy RJ, et al. Postoperative hypoxemia in morbidly obese patients with and without obstructive sleep apnea undergoing laparoscopic bariatric surgery. Anesth Analg. 2008;107:138-43.
59. El Shobary H, Christou N, Backman SB, et al. Effect of laparoscopic versus open gastric bypass surgery on postoperative pain and bowel function. Obes Surg. 2006;16:437-42.
60. Rawal N, Sjostrand U, Christoffersson E, et al. Comparison of intramuscular and epidural morphine for postoperative analgesia in the grossly obese: influence on postoperative ambulation and pulmonary function. Anesth Analg. 1984;63:583-92. (Pubitemid 14121094)
61. Brodsky JB, Merrell RC. Epidural administration of morphine postoperatively for morbidly obese patients. West J Med. 1984;140:750-3. (Pubitemid 14110732)
62. Kyzer S, Ramadan E, Gersch M, et al. Patient-controlled analgesia following vertical gastroplasty: a comparison with intramuscular narcotics. Obes Surg. 1995;5:18-21.
63. Choi YK, Brolin RE, Wagner BK, et al. Efficacy and safety of patient-controlled analgesia for morbidly obese patients following gastric bypass surgery. Obes Surg. 2000;10:154-9. (Pubitemid 30353186)
64. Michaloudis D, Fraidakis O, Petrou A, et al. Continuous spinal anesthesia/analgesia for perioperative management of morbidly obese patients undergoing laparotomy for gastroplastic surgery. Obes Surg. 2000;10:220-9.
65. Charghi R, Backman S, Christou N, et al. Patient controlled i.v. analgesia is an acceptable pain management strategy in morbidly obese patients undergoing gastric bypass surgery. A retrospective comparison with epidural analgesia. Can J Anaesth. 2003;50:672-8. (Pubitemid 37321972)
66. Pathiraja C, Silva N, Sharpe G, et al. Is continuous infiltration of local anaesthetic/PCA an acceptable alternate pain management strategy in morbidly obese patients undergoing gastric bypass surgery? A retrospective comparison with epidural analgesia. Sri Lankan Journal of Anaesthesiology. 2010;18:66-71.
67. De Baerdemaeker LE, Jacobs S, Pattyn P, et al. Influence of intraoperative opioid on postoperative pain and pulmonary function after laparoscopic gastric banding: remifentanil TCI vs sufentanil TCI in morbid obesity. Br J Anaesth. 2007;99:404-11. (Pubitemid 47316395)
68. Bidgoli J, Delesalle S, De Hert SG, et al. A randomised trial comparing sufentanil versus remifentanil for laparoscopic gastroplasty in the morbidly obese patient. Eur J Anaesthesiol. 2011;28:120-4.
69. Cottam DR, Fisher B, Atkinson J, et al. A randomized trial of bupivicaine pain pumps to eliminate the need for patient controlled analgesia pumps in primary laparoscopic Roux-en-Y gastric bypass. Obes Surg. 2007;17:595-600. (Pubitemid 46945416)
70. Kamal H. Ketamine as an adjuvant to morphine for patient controlled analgesia in morbidly obese patients. Journal of Medical Sciences. 2008;8:364-70.
71. Sollazzi L, Modesti C, Vitale F, et al. Preinductive use of clonidine and ketamine improves recovery and reduces postoperative pain after bariatric surgery. Surg Obes Relat Dis. 2009;5:67-71.
72. Govindarajan R, Ghosh B, Sathyamoorthy MK, et al. Efficacy of ketorolac in lieu of narcotics in the operative management of laparoscopic surgery for morbid obesity. Surg Obes Relat Dis. 2005;1:530-5. discussion 535-536.
73. Kamelgard JI, Kim KA, Atlas G. Combined preemptive and preventive analgesia in morbidly obese patients undergoing open gastric bypass: a pilot study. Surg Obes Relat Dis. 2005;1:12-6.
74. Feld JM, Hoffman WE, Stechert MM, et al. Fentanyl or dexmedetomidine combined with desflurane for bariatric surgery. J Clin Anesth. 2006;18:24-8. (Pubitemid 43330764)
75. Tufanogullari B, White PF, Peixoto MP, et al. Dexmedetomidine infusion during laparoscopic bariatric surgery: the effect on recovery outcome variables. Anesth Analg. 2008;106:1741-8.
76. Cabrera Schulmeyer MC, de la Maza J, Ovalle C, et al. Analgesic effects of a single preoperative dose of pregabalin after laparoscopic sleeve gastrectomy. Obes Surg. 2010;20:1678-81.
77. Strayhorn G. Transcutaneous electrical nerve stimulation and postoperative use of narcotic analgesics. J Natl Med Assoc. 1983;75:811-6. (Pubitemid 13014470)
78. Batistich S, Kendall A, Somers S. Analgesic requirements in morbidly obese patients. Anaesthesia. 2004;59:510-1. (Pubitemid 38578694)
79. Lee WJ, Huang MT, Yu PJ, et al. Laparoscopic vertical banded gastroplasty and laparoscopic gastric bypass: a comparison. Obes Surg. 2004;14:626-34. (Pubitemid 38716582)
80. Hamza MA, Schneider BE, White PF, et al. Heated and humidified insufflation during laparoscopic gastric bypass surgery: effect on temperature, postoperative pain, and recovery outcomes. J Laparoendosc Adv Surg Tech A. 2005;15:6-12. (Pubitemid 40381382)
81. Savel RH, Balasubramanya S, Lasheen S, et al. Beneficial effects of humidified, warmed carbon dioxide insufflation during laparoscopic bariatric surgery: a randomized clinical trial. Obes Surg. 2005;15:64-9. (Pubitemid 40203827)
82. Weingarten TN, Sprung J, Flores A, et al. Opioid requirements after laparoscopic bariatric surgery. Obes Surg. 2011;21:1407-12.
83. Steinmiller CL, Diederichs C, Roehrs TA, et al. Postsurgical patient-controlled opioid self-administration is greater in hospitalized abstinent smokers than nonsmokers. J Opioid Manag. 2012;8:227-35.